MicroRNA-30c analog C2 decreases plasma cholesterol and atherosclerosis without causing liver injury in preclinical studies

Journal:

Nature Communications

Published:

2026-04-24

DOI:

10.1038/s41467-026-72276-0

Affiliations:

5

Authors:

15

Go to article

Institutions	Authors	Share
NYU Langone Health, United States of America (USA)	10.000000 10.000000	0.67
State University of New York at Albany (SUNY Albany), United States of America (USA)	2.000000	0.13
Wake Forest University (WFU), United States of America (USA)	1.500000	0.10
University of Kentucky (UK), United States of America (USA)	1.000000	0.07
University of Tasmania (UTAS), Australia	0.500000	0.03

Interested in Cardiovascular Medicine and Haematology?